Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-09 Sale |
2023-08-10 06:50 am |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $18.27 | $965,402 | 17,836 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-11 09:23 am |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $20.4 | $1,078,068 | 17,836 (Direct) |
View |
| 2023-06-09 Sale |
2023-06-09 5:32 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $21.18 | $1,119,421 | 17,836 (Direct) |
View |
| 2023-05-09 Sale |
2023-05-10 4:11 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $21.41 | $1,131,478 | 17,836 (Direct) |
View |
| 2023-04-10 Sale |
2023-04-12 4:03 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $19.53 | $1,032,237 | 17,836 (Direct) |
View |
| 2023-03-13 Sale |
2023-03-14 4:42 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $22.53 | $1,190,674 | 17,836 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:49 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $26.83 | $1,417,909 | 17,836 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 4:18 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
173,988 | $23.11 | $4,020,056 | 17,836 (Direct) |
View |
| 2022-09-14 Sale |
2022-09-16 5:34 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
279,420 | $23.64 | $6,604,327 | 17,836 (Direct) |
View |
| 2022-07-01 Sale |
2022-07-05 4:09 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
62,292 | $19 | $1,183,430 | 17,836 (Direct) |
View |
| 2022-04-14 Sale |
2022-04-18 9:00 pm |
ARVINAS INC. | ARVN | Morrison Briggs Director |
20,960 | $66.44 | $1,392,616 | 20,470 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 4:05 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
104,173 | $17.48 | $1,820,735 | 17,836 (Direct) |
View |
| 2022-01-14 Sale |
2022-01-19 9:00 pm |
ARVINAS INC. | ARVN | Morrison Briggs Director |
20,960 | $65.55 | $1,374,021 | 41,430 (Direct) |
View |
| 2021-12-17 Sale |
2021-12-20 6:44 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $20 | $703,120 | 48,336 (Direct) |
View |
| 2021-09-17 Sale |
2021-09-21 4:35 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
70,312 | $20.07 | $1,411,018 | 48,336 (Direct) |
View |
| 2021-02-17 Purchase |
2021-02-17 6:05 pm |
Codiak BioSciences Inc. | CDAK | Morrison Briggs Director |
4,761 | $21 | $99,981 | 4,761 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-10 4:23 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $20.55 | $722,403 | 48,336 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-12 5:55 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $20.04 | $1,611,577 | 46,565 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-26 Option Award |
2024-06-27 4:54 pm |
N/A 2034-06-26 |
Carisma Therapeutics Inc. | CARM | Morrison Briggs Director |
19,350 | $0 | 19,350 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
27,200 | $0 | 27,200 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 5:51 pm |
N/A 2034-05-28 |
ARVINAS INC. | ARVN | Morrison Briggs Director |
14,969 | $0 | 39,066 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:49 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
17,000 | $0 | 34,836 (Direct) |
View |
| 2023-08-09 Exercise |
2023-08-10 06:50 am |
2027-02-06 N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-08-09 Exercise |
2023-08-10 06:50 am |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $8.77 | 17,836 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 09:23 am |
N/A 2027-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 09:23 am |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $8.77 | 17,836 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 5:07 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:27 pm |
N/A 2033-06-14 |
ARVINAS INC. | ARVN | Morrison Briggs Director |
16,908 | $0 | 36,884 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:27 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
27,200 | $0 | 27,200 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-09 5:32 pm |
N/A 2027-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-09 5:32 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
28,273 | $8.77 | 17,836 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-09 5:32 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
24,582 | $6.38 | 17,836 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:11 pm |
N/A 2033-06-06 |
Carisma Therapeutics Inc. | CARM | Morrison Briggs Director |
38,700 | $0 | 38,700 (Direct) |
View |
| 2023-05-09 Exercise |
2023-05-10 4:11 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-05-09 Exercise |
2023-05-10 4:11 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $6.38 | 17,836 (Direct) |
View |
| 2023-04-10 Exercise |
2023-04-12 4:03 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-04-10 Exercise |
2023-04-12 4:03 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $6.38 | 17,836 (Direct) |
View |
| 2023-03-13 Exercise |
2023-03-14 4:42 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $0 | 17,836 (Direct) |
View |
| 2023-03-13 Exercise |
2023-03-14 4:42 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $6.38 | 17,836 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 9:21 pm |
N/A 2030-07-23 |
Carisma Therapeutics Inc. | CARM | Morrison Briggs Director |
109,674 | $0 | 109,674 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:49 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $0 | 17,836 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:49 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $6.38 | 17,836 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:02 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
32,000 | $28.55 | 32,000 (Direct) |
View |
| 2022-09-19 Exercise |
2022-09-21 4:18 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
173,988 | $10.9 | 17,836 (Direct) |
View |
| 2022-09-19 Exercise |
2022-09-21 4:18 pm |
N/A 2025-09-09 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
173,988 | $0 | 17,836 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 5:34 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
226,386 | $7.2 | 17,836 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-16 5:34 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
53,034 | $10.9 | 17,836 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 5:34 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
279,420 | $0 | 17,836 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-05 4:09 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
62,292 | $7.2 | 17,836 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-05 4:09 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
62,292 | $0 | 17,836 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 8:00 pm |
N/A 2032-06-15 |
ARVINAS INC. | ARVN | Morrison Briggs Director |
10,192 | $0 | 10,192 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:41 pm |
N/A 2032-05-31 |
Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director |
11,600 | $0 | 11,600 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:25 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 9:00 pm |
N/A N/A |
ARVINAS INC. | ARVN | Morrison Briggs Director |
16,188 | $16 | 20,470 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 9:00 pm |
N/A 2028-09-25 |
ARVINAS INC. | ARVN | Morrison Briggs Director |
16,188 | $0 | 20,470 (Direct) |
View |
| 2022-04-01 Exercise(A) |
2022-04-13 4:09 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
73,673 | $7.2 | 20,964 (Direct) |
View |
| 2022-04-01 Exercise(A) |
2022-04-13 4:09 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
73,673 | $0 | 20,964 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
73,673 | $10.9 | 17,836 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 4:05 pm |
N/A 2025-09-09 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
73,673 | $0 | 17,836 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:32 pm |
N/A 2032-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
160,000 | $15.79 | 160,000 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 9:00 pm |
N/A N/A |
ARVINAS INC. | ARVN | Morrison Briggs Director |
16,188 | $16 | 41,430 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 9:00 pm |
N/A 2028-09-25 |
ARVINAS INC. | ARVN | Morrison Briggs Director |
16,188 | $0 | 41,430 (Direct) |
View |
| 2021-12-17 Exercise |
2021-12-20 6:44 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $10.9 | 48,336 (Direct) |
View |
| 2021-12-17 Exercise |
2021-12-20 6:44 pm |
N/A 2025-09-09 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $0 | 48,336 (Direct) |
View |
| 2021-09-17 Exercise |
2021-09-21 4:35 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
70,312 | $7.2 | 48,336 (Direct) |
View |
| 2021-09-17 Exercise |
2021-09-21 4:35 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
70,312 | $0 | 48,336 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 8:00 pm |
N/A 2021-06-07 |
ARVINAS INC. | ARVN | Morrison Briggs Director |
7,511 | $0 | 7,511 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:53 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-04 4:30 pm |
N/A 2031-04-29 |
Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director |
23,200 | $0 | 23,200 (Direct) |
View |
Ownership |
2021-04-29 4:58 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director |
0 | $0 | 46,570 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 4:23 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $7.2 | 48,336 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 4:23 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $0 | 48,336 (Direct) |
View |
| 2021-01-31 Other |
2021-02-05 4:21 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
1,771 | $12 | 245,107 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:21 pm |
N/A 2031-02-03 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
195,000 | $0 | 245,107 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:55 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $7.2 | 46,565 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:55 pm |
N/A 2025-06-01 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $0 | 46,565 (Direct) |
View |